Cyber Resilience

CVE-2025-3569

MediumPublic PoC

Published: 14 April 2025

Published
14 April 2025
Modified
10 February 2026
KEV Added
Patch
CVSS Score v4 5.3 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
EPSS Score 0.0020 41.5th percentile
Risk Priority 11 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2025-3569 is a medium-severity Incorrect Privilege Assignment (CWE-266) vulnerability in Jameszbl Db-Hospital-Drug. Its CVSS base score is 5.3 (Medium).

Operationally, ranked at the 41.5th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.

EU & UK References

Vulnerability details

A vulnerability was found in JamesZBL/code-projects db-hospital-drug 1.0 and classified as critical. Affected by this issue is some unknown functionality of the file ShiroConfig.java. The manipulation leads to improper authorization. The attack may be launched remotely. The exploit has been…

more

disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

jameszbl
db-hospital-drug
1.0

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-285 CWE-266

Documented procedures facilitate correct implementation and ongoing management of authorization decisions.

addresses: CWE-285 CWE-266

Periodic reviews identify and correct flaws in authorization decisions or enforcement.

addresses: CWE-285 CWE-266

Specifying access authorizations for each account and requiring approvals for account requests enforces proper authorization decisions.

addresses: CWE-266 CWE-285

The control requires explicit definition of separated access authorizations, making incorrect privilege assignments that bundle conflicting duties harder to implement.

addresses: CWE-266 CWE-285

Ensures privileges are assigned only as necessary rather than incorrectly over-granted.

addresses: CWE-285

The control's documentation requirement reduces improper authorization by ensuring only mission-justified actions bypass authentication.

addresses: CWE-285

Establishing permitted attributes and values, plus auditing changes, ensures authorization decisions are based on correctly managed policy data.

addresses: CWE-285

Explicitly mandates authorizing remote access types before permitting connections, directly mitigating improper authorization.

References